374644 Exploring Opportunities for Information Exchange and Mutual Development of Enabling Technologies

Tuesday, November 18, 2014: 8:55 AM
202 (Hilton Atlanta)
Srinivas Tummala, Chemical Development, Bristol-Myers Squibb, New Brunswick, NJ, Kevin D. Seibert, Chemical Product Research and Development, Eli Lilly and Company, Indianapolis, IN and Margaret Faul, Amgen, Thousand Oaks, CA

Abstracts:


Extended Abstract: File Not Uploaded
See more of this Session: Pre-Competitive Collaborations in the Pharma Industry: Perspective and Opportunities
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum